Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

CCM vs ISRG vs SYK vs MDT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CCM
Concord Medical Services Holdings Limited

Medical - Care Facilities

HealthcareNYSE • CN
Market Cap$836K
5Y Perf.-58.7%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$159.85B
5Y Perf.+132.8%
SYK
Stryker Corporation

Medical - Devices

HealthcareNYSE • US
Market Cap$109.33B
5Y Perf.+45.8%
MDT
Medtronic plc

Medical - Devices

HealthcareNYSE • IE
Market Cap$97.62B
5Y Perf.-22.8%

CCM vs ISRG vs SYK vs MDT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CCM logoCCM
ISRG logoISRG
SYK logoSYK
MDT logoMDT
IndustryMedical - Care FacilitiesMedical - Instruments & SuppliesMedical - DevicesMedical - Devices
Market Cap$836K$159.85B$109.33B$97.62B
Revenue (TTM)$366M$10.58B$25.12B$35.48B
Net Income (TTM)$-163M$2.98B$3.25B$4.61B
Gross Margin-11.4%66.3%63.5%61.9%
Operating Margin-131.0%30.5%22.4%17.9%
Forward P/E1.4x43.3x19.1x13.8x
Total Debt$3.93B$303M$14.86B$28.52B
Cash & Equiv.$216M$3.37B$4.01B$2.22B

CCM vs ISRG vs SYK vs MDTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CCM
ISRG
SYK
MDT
StockMay 20May 26Return
Concord Medical Ser… (CCM)10041.3-58.7%
Intuitive Surgical,… (ISRG)100232.8+132.8%
Stryker Corporation (SYK)100145.8+45.8%
Medtronic plc (MDT)10077.2-22.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: CCM vs ISRG vs SYK vs MDT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MDT leads in 4 of 7 categories, making it the strongest pick for capital preservation and lower volatility and dividend income and shareholder returns. Intuitive Surgical, Inc. is the stronger pick specifically for growth and revenue expansion and profitability and margin quality. CCM also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
CCM
Concord Medical Services Holdings Limited
The Value Play

CCM is the clearest fit if your priority is value.

  • Lower P/E (1.4x vs 43.3x)
Best for: value
ISRG
Intuitive Surgical, Inc.
The Growth Play

ISRG is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.

  • Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
  • 5.5% 10Y total return vs SYK's 179.2%
  • 20.5% revenue growth vs CCM's -28.6%
  • 28.2% margin vs CCM's -44.6%
Best for: growth exposure and long-term compounding
SYK
Stryker Corporation
The Value Pick

SYK is the clearest fit if your priority is valuation efficiency.

  • PEG 1.28 vs MDT's 35.17
Best for: valuation efficiency
MDT
Medtronic plc
The Income Pick

MDT carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 36 yrs, beta 0.42, yield 3.7%
  • Lower volatility, beta 0.42, Low D/E 59.1%, current ratio 1.85x
  • Beta 0.42, yield 3.7%, current ratio 1.85x
  • Beta 0.42 vs ISRG's 1.00
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthISRG logoISRG20.5% revenue growth vs CCM's -28.6%
ValueCCM logoCCMLower P/E (1.4x vs 43.3x)
Quality / MarginsISRG logoISRG28.2% margin vs CCM's -44.6%
Stability / SafetyMDT logoMDTBeta 0.42 vs ISRG's 1.00
DividendsMDT logoMDT3.7% yield, 36-year raise streak, vs SYK's 1.2%, (2 stocks pay no dividend)
Momentum (1Y)MDT logoMDT-5.5% vs SYK's -24.5%
Efficiency (ROA)MDT logoMDT175.8% ROA vs CCM's -2.4%, ROIC 6.0% vs -7.7%

CCM vs ISRG vs SYK vs MDT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CCMConcord Medical Services Holdings Limited
FY 2024
Services and other revenues
80.1%$372M
Medicine income
17.9%$83M
Equipment Leasing Revenues
2.0%$9M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B
SYKStryker Corporation
FY 2025
MedSurg
62.3%$15.6B
Orthopaedics
37.7%$9.5B
MDTMedtronic plc
FY 2025
Cardiac and Vascular Group
37.3%$12.5B
Neuroscience Group
29.4%$9.8B
Medical Surgical
25.1%$8.4B
Diabetes Group
8.2%$2.8B

CCM vs ISRG vs SYK vs MDT — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGSYK

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 5 of 6 comparable metrics.

MDT is the larger business by revenue, generating $35.5B annually — 97.0x CCM's $366M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to CCM's -44.6%. On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCCM logoCCMConcord Medical S…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
RevenueTrailing 12 months$366M$10.6B$25.1B$35.5B
EBITDAEarnings before interest/tax-$359M$3.8B$6.3B$9.4B
Net IncomeAfter-tax profit-$163M$3.0B$3.2B$4.6B
Free Cash FlowCash after capex$0$2.8B$4.3B$5.4B
Gross MarginGross profit ÷ Revenue-11.4%+66.3%+63.5%+61.9%
Operating MarginEBIT ÷ Revenue-131.0%+30.5%+22.4%+17.9%
Net MarginNet income ÷ Revenue-44.6%+28.2%+12.9%+13.0%
FCF MarginFCF ÷ Revenue-2.1%+26.8%+17.1%+15.2%
Rev. Growth (YoY)Latest quarter vs prior year-8.3%+23.0%+11.4%+8.8%
EPS Growth (YoY)Latest quarter vs prior year+84.0%+18.8%+56.0%-11.9%
ISRG leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

CCM leads this category, winning 4 of 7 comparable metrics.

At 21.1x trailing earnings, MDT trades at a 63% valuation discount to ISRG's 57.2x P/E. Adjusting for growth (PEG ratio), SYK offers better value at 2.29x vs MDT's 35.17x — a lower PEG means you pay less per unit of expected earnings growth.

MetricCCM logoCCMConcord Medical S…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
Market CapShares × price$835,830$159.8B$109.3B$97.6B
Enterprise ValueMkt cap + debt − cash$547M$156.8B$120.2B$123.9B
Trailing P/EPrice ÷ TTM EPS-0.02x57.19x33.98x21.09x
Forward P/EPrice ÷ next-FY EPS est.1.37x43.35x19.06x13.80x
PEG RatioP/E ÷ EPS growth rate2.63x2.29x35.17x
EV / EBITDAEnterprise value multiple43.28x19.76x14.06x
Price / SalesMarket cap ÷ Revenue0.01x15.88x4.35x2.91x
Price / BookPrice ÷ Book value/share0.00x9.10x4.87x2.04x
Price / FCFMarket cap ÷ FCF64.18x25.53x18.83x
CCM leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 7 of 9 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-10 for CCM. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to CCM's 2.43x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs CCM's 3/9, reflecting solid financial health.

MetricCCM logoCCMConcord Medical S…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
ROE (TTM)Return on equity-9.8%+16.9%+15.0%+9.4%
ROA (TTM)Return on assets-2.4%+14.8%+6.9%+175.8%
ROICReturn on invested capital-7.7%+15.0%+11.4%+6.0%
ROCEReturn on capital employed-12.2%+16.5%+13.0%+7.5%
Piotroski ScoreFundamental quality 0–93666
Debt / EquityFinancial leverage2.43x0.02x0.66x0.59x
Net DebtTotal debt minus cash$3.7B-$3.1B$10.8B$26.3B
Cash & Equiv.Liquid assets$216M$3.4B$4.0B$2.2B
Total DebtShort + long-term debt$3.9B$303M$14.9B$28.5B
Interest CoverageEBIT ÷ Interest expense-2.40x6.72x9.08x
ISRG leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ISRG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $16,174 today (with dividends reinvested), compared to $1,693 for CCM. Over the past 12 months, MDT leads with a -5.5% total return vs SYK's -24.5%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.1% vs CCM's -24.4% — a key indicator of consistent wealth creation.

MetricCCM logoCCMConcord Medical S…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
YTD ReturnYear-to-date+34.4%-19.9%-17.8%-20.0%
1-Year ReturnPast 12 months-23.0%-16.4%-24.5%-5.5%
3-Year ReturnCumulative with dividends-56.8%+48.5%+2.4%-6.3%
5-Year ReturnCumulative with dividends-83.1%+61.7%+17.5%-29.2%
10-Year ReturnCumulative with dividends-87.5%+549.2%+179.2%+24.3%
CAGR (3Y)Annualised 3-year return-24.4%+14.1%+0.8%-2.1%
ISRG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ISRG and MDT each lead in 1 of 2 comparable metrics.

MDT is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than ISRG's 1.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ISRG currently trades 74.5% from its 52-week high vs CCM's 53.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCCM logoCCMConcord Medical S…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
Beta (5Y)Sensitivity to S&P 5000.51x1.00x0.52x0.42x
52-Week HighHighest price in past year$10.77$603.88$404.87$106.33
52-Week LowLowest price in past year$3.18$427.84$284.97$75.91
% of 52W HighCurrent price vs 52-week peak+53.3%+74.5%+70.5%+71.6%
RSI (14)Momentum oscillator 0–10071.043.626.629.2
Avg Volume (50D)Average daily shares traded11K1.8M2.1M7.9M
Evenly matched — ISRG and MDT each lead in 1 of 2 comparable metrics.

Analyst Outlook

MDT leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: CCM as "Buy", ISRG as "Buy", SYK as "Buy", MDT as "Buy". Consensus price targets imply 43.8% upside for MDT (target: $110) vs 36.5% for SYK (target: $390). For income investors, MDT offers the higher dividend yield at 3.65% vs SYK's 1.18%.

MetricCCM logoCCMConcord Medical S…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$622.60$389.62$109.50
# AnalystsCovering analysts2555049
Dividend YieldAnnual dividend ÷ price+1.2%+3.7%
Dividend StreakConsecutive years of raises03436
Dividend / ShareAnnual DPS$3.36$2.78
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.4%0.0%+3.3%
MDT leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CCM leads in 1 (Valuation Metrics). 1 tied.

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 3 of 6 categories
Loading custom metrics...

CCM vs ISRG vs SYK vs MDT: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CCM or ISRG or SYK or MDT a better buy right now?

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus -28. 6% for Concord Medical Services Holdings Limited (CCM). Medtronic plc (MDT) offers the better valuation at 21. 1x trailing P/E (13. 8x forward), making it the more compelling value choice. Analysts rate Concord Medical Services Holdings Limited (CCM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CCM or ISRG or SYK or MDT?

On trailing P/E, Medtronic plc (MDT) is the cheapest at 21.

1x versus Intuitive Surgical, Inc. at 57. 2x. On forward P/E, Concord Medical Services Holdings Limited is actually cheaper at 1. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Stryker Corporation wins at 1. 28x versus Medtronic plc's 35. 17x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — CCM or ISRG or SYK or MDT?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +61. 7%, compared to -83. 1% for Concord Medical Services Holdings Limited (CCM). Over 10 years, the gap is even starker: ISRG returned +549. 2% versus CCM's -87. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CCM or ISRG or SYK or MDT?

By beta (market sensitivity over 5 years), Medtronic plc (MDT) is the lower-risk stock at 0.

42β versus Intuitive Surgical, Inc. 's 1. 00β — meaning ISRG is approximately 135% more volatile than MDT relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 2% for Concord Medical Services Holdings Limited — giving it more financial flexibility in a downturn.

05

Which is growing faster — CCM or ISRG or SYK or MDT?

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus -28. 6% for Concord Medical Services Holdings Limited (CCM). On earnings-per-share growth, the picture is similar: Medtronic plc grew EPS 30. 8% year-over-year, compared to -3. 6% for Concord Medical Services Holdings Limited. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CCM or ISRG or SYK or MDT?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -80. 3% for Concord Medical Services Holdings Limited — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -138. 6% for CCM. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CCM or ISRG or SYK or MDT more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Stryker Corporation (SYK) is the more undervalued stock at a PEG of 1. 28x versus Medtronic plc's 35. 17x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Concord Medical Services Holdings Limited (CCM) trades at 1. 4x forward P/E versus 43. 3x for Intuitive Surgical, Inc. — 42. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MDT: 43. 8% to $109. 50.

08

Which pays a better dividend — CCM or ISRG or SYK or MDT?

In this comparison, MDT (3.

7% yield), SYK (1. 2% yield) pay a dividend. CCM, ISRG do not pay a meaningful dividend and should not be held primarily for income.

09

Is CCM or ISRG or SYK or MDT better for a retirement portfolio?

For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

52), 1. 2% yield, +179. 2% 10Y return). Both have compounded well over 10 years (SYK: +179. 2%, ISRG: +549. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CCM and ISRG and SYK and MDT?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CCM is a small-cap quality compounder stock; ISRG is a mid-cap high-growth stock; SYK is a mid-cap quality compounder stock; MDT is a mid-cap income-oriented stock. SYK, MDT pay a dividend while CCM, ISRG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

CCM

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Stocks Like

SYK

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Stocks Like

MDT

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CCM and ISRG and SYK and MDT on the metrics below

Revenue Growth>
%
(CCM: -8.3% · ISRG: 23.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.